SEARCH

SEARCH BY CITATION

References

  • 1
    Sjobring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002; 100: 44707.
  • 2
    Ruggeri ZM. Structure and biosynthesis of von Willebrand factor. In: RuggeriZM, ed. Von Willebrand Factor and the Mechanisms of Platelet Function. Berlin: Springer, 1998: 3377.
  • 3
    Nogami K, Shima M, Nishiya K, Hosokawa K, Saenko EL, Sakurai Y, Shibata M, Suzuki H, Tanaka I, Yoshioka A. A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation. Blood 2002; 99: 39938.
  • 4
    Ware J, Ruggeri ZM. Platelet membrane glycoproteins. In: Wiley Encyclopedia of Molecular Medicine. London: John Wiley & Sons, 2002: 2158520.
  • 5
    Ruggeri ZM, Savage B. Biological functions of von Willebrand factor. In: RuggeriZM, ed. Von Willebrand Factor and the Mechanisms of Platelet Function. Berlin: Springer, 1998: 79109.
  • 6
    Sen U, Vasudevan S, Subbarao G, McClintock RA, Celikel R, Ruggeri ZM, Varughese KI. Crystal structure of the von Willebrand factor modulator botrocetin. Biochemistry 2000; 40: 34552.
  • 7
    Fujimoto T, Hawiger J. Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Nature 1982; 297: 1546.
  • 8
    Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 112.
  • 9
    Ruggeri ZM, Bader R, De Marco L. Glanzmann thrombasthenia: Deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci USA 1982; 79: 603841.
  • 10
    Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 47986.
  • 11
    Tangelder GJ, Slaaf DW, Arts T, Reneman RS. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol 1988; 254: H1059H1064.
  • 12
    Strony J, Beaudoin A, Brands D, Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 1993; 265: H1787H1796.
  • 13
    Siegel JM, Markou CP, Ku DN, Hanson SR. A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng 1994; 116: 44651.
  • 14
    Mailhac A, Badimon JJ, Fallon JT, Fernandez-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 1994; 90: 98896.
  • 15
    Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 317184.
  • 16
    Mayadas TN, Wagner DD. von Willebrand factor biosynthesis and processing. Ann N Y Acad Sci 1991; 614: 15366.
  • 17
    Mayadas TN, Wagner DD. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci USA 1992; 89: 35315.
  • 18
    Fowler WE, Fretto LJ. Electron microscopy of von Willebrand factor. In: ZimmermanTS, RuggeriZM, eds. Coagulation and Bleeding Disorders. The Role of Factor VIII and Von Willebrand Factor. New York: Marcel Dekker, 1989: 18193.
  • 19
    Siediecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 293950.
  • 20
    Novak L, Deckmyn H, Damjanovich S, Harsfalvi J. Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood 2002; 99: 20706.
  • 21
    Nichols WC, Cooney KA, Ginsburg D, Ruggeri ZM. von Willebrand disease. In: LoscalzoJ, SchaferAI, eds. Thrombosis and Hemorrhage. Philadelphia: Lippincott, Williams & Wilkins, 2003: 53959.
  • 22
    Arya M, Anvari B, Romo GM, Cruz MA, Dong J-F, McIntire LV, Moake JL, Lopez JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002; 99: 39717.
  • 23
    Kasirer-Friede A, Ware J, Leng L, Marchese P, Ruggeri ZM, Shattil SJ. Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin αIIbβ3. J Biol Chem 2002; 277: 1194956.
  • 24
    Bowie EJ, Solberg LA Jr, Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 1986; 78: 2630.
  • 25
    Stel HV, Sakariassen KS, De Groot PG, Van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 8590.
  • 26
    Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 82331.
  • 27
    Van Der Kwast TH, Stel HV, Cristen E. Localization of factor VIII-procoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. Blood 1986; 67: 2227.
  • 28
    Takeuchi M, Nagura H, Kaneda T. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood 1988; 72: 8504.
  • 29
    Celikel R, Varughese KI, Madhusudan Yoshioka A, Ware J, Ruggeri ZM. Crystal structure of von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nature Structural Biol 1998; 5: 18994.
  • 30
    Bienkowska J, Cruz MA, Handin RI, Liddington RC. The von Willebrand factor A3 domain does not contain a metal Ion-dependent adhesion site motif. J Biol Chem 1997; 272: 251627.
  • 31
    Huizinga EG, Van Der Plas RM, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 1997; 5: 114756.
  • 32
    Romijn RAP, Bouma B, Wuyster W, Gros P, Kroon J, Sixma JJ, Huizinga EG. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem 2001; 276: 998591.
  • 33
    Mazzucato M, Spessotto P, Masotti A, De Appollonia L, Cozzi MR, Yoshioka A, Perris R, Colombatti A, De Marco L. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. J Biol Chem 1999; 274: 303341.
  • 34
    Mazzucato M, Cozzi MR, Pradella P, Perissinotto D, Malmstrom A, Morgelin M, Spessotto P, Colombatti A, De Marco L, Perris R. Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. FASEB J 2002; 16: 190311.
  • 35
    Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, Deckmyn H. Inhibition of the von Willebrand (VWF)–collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood 2002; 99: 36238.
  • 36
    Ribba AS, Loisel I, Lavergne JM, Juhan-Vague I, Obert B, Cherel G, Meyer D, Girma JP. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001; 86: 84854.
  • 37
    Savage B, Sixma JJ, Ruggeri ZM. Functional self association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA 2002; 99: 42530.
  • 38
    Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azacar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII. von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 14325.
  • 39
    Ruggeri ZM, Mannucci PM, Federici AB, Lombardi R, Zimmerman TS. Multimeric composition of Factor VIII/von Willebrand factor following administration of DDAVP. Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 12728.
  • 40
    Xie L, Chesterman CN, Hogg PJ. Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med 2001; 193: 13419.
  • 41
    Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (Types IIC, IID and IIE). J Clin Invest 1986; 77: 94751.
  • 42
    Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 630610.
  • 43
    Dent JA, Galbusera M, Ruggeri ZM. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991; 88: 77482.
  • 44
    Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98: 165461.
  • 45
    Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98: 16626.
  • 46
    Levy GG, Nichols WC, Lian EC, Foroud T, McClintock JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai H-M. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 48894.
  • 47
    Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 4105963.
  • 48
    Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589600.
  • 49
    Ajzenberg N, Denis CV, Veyradier A, Girma J-P, Meyer D, Baruch D. Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy. Thromb Haemost 2002; 87: 80811.
  • 50
    Dong J-F, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultra-large von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 40339.
  • 51
    Blot E, Deecaudin D, Veyradier A, Bardier A, Zagame O-L, Pouillart P. Cancer-related thrombotic microangiopathy secondary to von Willebrand factor-cleaving protease deficiency. Thromb Res 2002; 106: 12730.
  • 52
    Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 28997.
  • 53
    Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate–receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 65766.
  • 54
    Celikel R, Ruggeri ZM, Varughese KI. von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nature Structural Biol 2000; 7: 8814.
  • 55
    Huizinga EG, Tsuji S, Romijn RAP, Schiphorst ME, De Groot PG, Sixma JJ, Gros P. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 2002; 297: 117629.
  • 56
    Mazzucato M, Pradella P, Cozzi MR, De Marco L, Ruggeri ZM. Sequential cytoplasmic calcium signals in a two-stage platelet activation process induced by the glycoprotein Ibα mechanoreceptor. Blood 2002; 100: 2793800.
  • 57
    Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Current Opinion Hematol 2001; 8: 2706.
  • 58
    Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 2335261.
  • 59
    Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 94: 1728.
  • 60
    Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 38592.
  • 61
    Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nature Med 2002; 8: 24752.
  • 62
    Ware JA, Heistad DD. Platelet–endothelium interactions. N Engl J Med 1993; 328: 62835.
  • 63
    Gross PL, Aird WC. The endothelium and thrombosis. Semin Thromb Hemost 2000; 26: 46378.
  • 64
    Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB. The endothelial cell Ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 135160.
  • 65
    Esmon NL, Carroll RC, Esmon CT. Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983; 258: 1223842.
  • 66
    Frenette PS, Wagner DD. Adhesion molecules – Part I. N Engl J Med 1996; 334: 15269.
  • 67
    Frenette PS, Wagner DD. Adhesion molecules – Part II. Blood vessels and blood cells. N Engl J Med 1996; 335: 435.
  • 68
    Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068101.
  • 69
    Cheresh DA, Berliner AS, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 94553.
  • 70
    Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 74504.
  • 71
    André P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000; 96: 33228.
  • 72
    Lusis AJ. Atherosclerosis. Nature 2000; 407: 23341.
  • 73
    Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 11526.
  • 74
    Sachais BS. Platelet–endothelial interactions in atherosclerosis. Current Atherosclerosis Reports 2001; 3: 4126.
  • 75
    Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, Hoylaerts MF. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 2002; 99: 448693.
  • 76
    Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 2001; 98: 14248.
  • 77
    Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000; 101: 22905.